Trials / Completed
CompletedNCT03973086
To Assess the Efficacy of CitruSlim® on Body Composition as Well as Metabolic and Hormonal Factors in Overweight and Obese Individuals
A Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy of CitruSlim® on Body Composition as Well as Metabolic and Hormonal Factors in Overweight and Obese Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
CitruSlim® can promote healthy weight loss by promoting anabolic state during weight loss programs, prevent the body from storing fat, reduce appetites and maintain healthy cholesterol and blood glucose level during weight loss program. This study focuses to prove the efficacy and safety of the product in a population of overweight and obese individual.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Citrus flavonone-O-glycosides- LD | Low Dose of 200 mg |
| DIETARY_SUPPLEMENT | Citrus flavonone-O-glycosides- HD | High Dose of 400 mg |
| DIETARY_SUPPLEMENT | Placebo | Placebo (Microcrystalline Cellulose) of 400 mg |
Timeline
- Start date
- 2019-06-04
- Primary completion
- 2020-05-30
- Completion
- 2020-09-18
- First posted
- 2019-06-04
- Last updated
- 2021-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03973086. Inclusion in this directory is not an endorsement.